International Journal of Infectious Diseases (Mar 2023)

Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study

  • Bruno Märkl,
  • Sebastian Dintner,
  • Tina Schaller,
  • Eva Sipos,
  • Elisabeth Kling,
  • Silvia Miller,
  • Francisco Farfán López,
  • Przemyslaw Grochowski,
  • Nic Reitsam,
  • Johanna Waidhauser,
  • Klaus Hirschbühl,
  • Oliver Spring,
  • Andre Fuchs,
  • Thomas Wibmer,
  • Peter Boor,
  • Martin Beer,
  • Claudia Wylezich

Journal volume & issue
Vol. 128
pp. 51 – 57

Abstract

Read online

Objectives: Omicron lineages BA.1/2 are considered to cause mild clinical courses. Nevertheless, fatal cases after those infections are recognized but little is known about risk factors. Methods: A total of 23 full and three partial autopsies in deceased with known Omicron BA.1/2 infections have been consecutively performed. The investigations included histology, blood analyses, and molecular virus detection. Results: COVID-19-associated diffuse alveolar damage was found in only eight cases (31%). This rate is significantly lower compared with previous studies, including non-Omicron variants, where rates between 69% and 92% were observed. Neither vaccination nor known risk factors were significantly associated with a direct cause of death by COVID-19. Only those patients who were admitted to the clinic because of COVID-19 but not for other reasons had a significant association with a direct COVID-19 –caused death (P >0.001). Conclusion: Diffuse alveolar damage still occurred in the Omicron BA.1/BA.2 era but at a considerably lower frequency than seen with previous variants of concern. None of the known risk factors discriminated the cases with COVID-19-caused death from those that died because of a different disease. Therefore, the host's genomics might play a key role in this regard. Further studies should elucidate the existence of such a genomic risk factor.

Keywords